Process economics for large scale rAAV manufacturing
Cost-effective LV production for small & large scale suspension system
#1 Leader for small to large scale viral vector production
in vivo mRNA delivery using ready-to-use lipid-based nanoparticles
New range of cationic lipids for LNP formulation
Gold standard for in vivo delivery of DNA, siRNA, shRNA and miRNA
High yields in suspension CHO & HEK-293
Enhanced transient protein production in CHO cells
Best-in-class DNA transfection reagent
Versatile DNA/siRNA transfection reagent
mRNA transfection reagent for hard-to-transfect cells
Robust transfection reagent for automated or manual High Throughput Screening
Protein, antibody and peptide delivery reagent
siRNA, miRNA and other oligonucleotides
Optimize your process and prepare for scale up with fewer trials
Tailor-made DNA plasmid that really fits your needs
Plasmid DNA manufacturing using an unique process for Research, HQ and GMP grades
Whole plasmid Sequencing of multiple DNA plasmids in one shot with 100% coverage
pPLUS® AAV-Helper is a novel plasmid helper designed for AAV production.
Discover our range of ready to use plasmid templates
Process development to manufacturing of proteins at Research, Hq and GMP grade
Achieving performance, cost-effectiveness and time to market.
All resources related to Cell and Gene Therapy
Find the best answer possible
Search for publications related to Polyplus transfection reagents
Achieving targeting efficiency, safety and time to market
Achieving targeting efficiency, safety and time to market.
All resources related to RNA/DNA therapeutics
Improve yield, function and quality
Powerful transfection reagents for high protein yields
All resources related to Protein production
Choose among a broad range of life science dedicated delivery solutions
Choose among a broad range of powerful transfection reagents for your everyday experiments
All resources related to Nucleic Acid service
Explore our career opportunities
Explore all our job offers
Success of Gene and Cell Therapies is dependent on efficient production of viral vectors that require optimized transfection reagents and viral vector engineering.
RNA/DNA in vivo delivery is the most powerful alternative to viral vectors for nucleic acid-based therapies. They bring reliability, safety and costs.
Broad range of solutions is needed for manufacturing of functional proteins or antibodies at the desired scale in bacteria, yeast and mammalian cell expression systems.
Optimised plasmid engineering and specific transfection reagents are key to enable protein expression in a wide range of adherent and suspension mammalian cell types.